Affordable Access

Access to the full text

RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity

Authors
  • Hu, Xiao1
  • Moisan, Jacques1
  • Majchrzak, Kinga2
  • Lesch, Chuck1
  • Wang, Yahong1
  • Sanchez, Brian1
  • Liu, Xikui1
  • Morgan, Rodney1
  • Mertz, David1
  • Bousley, Dick1
  • van Huis, Chad1
  • Skalitzky, Don1
  • Taylor, Clarke1
  • Aicher, Thomas1
  • Toogood, Peter1
  • Zou, Weiping3
  • Glick, Gary3
  • Paulos, Chrystal2
  • Carter, Laura1
  • 1 Lycera Corp, Ann Arbor, MI, USA , Ann Arbor (United States)
  • 2 Medical University of South Carolina, Charleston, SC, USA , Charleston (United States)
  • 3 University of Michigan, Ann Arbor, MI, USA , Ann Arbor (United States)
Type
Published Article
Journal
Journal for ImmunoTherapy of Cancer
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Nov 04, 2015
Volume
3
Issue
Suppl 2
Identifiers
DOI: 10.1186/2051-1426-3-S2-P23
Source
Springer Nature
Keywords
License
Green
Report this publication

Statistics

Seen <100 times